Consilium Wealth Advisory’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Buy
7,458
+3,918
+111% +$876K 0.54% 34
2025
Q4
$606K Hold
3,540
0.22% 63
2025
Q3
$474K Hold
3,540
0.18% 71
2025
Q2
$345K Hold
3,540
0.15% 76
2025
Q1
$257K Hold
3,540
0.13% 80
2024
Q4
$256K Hold
3,540
0.12% 83
2024
Q3
$289K Hold
3,540
0.16% 73
2024
Q2
$377K Hold
3,540
0.21% 63
2024
Q1
$344K Hold
3,540
0.19% 69
2023
Q4
$277K Hold
3,540
0.17% 74
2023
Q3
$222K Hold
3,540
0.16% 80
2023
Q2
$228K Buy
+3,540
New +$200K 0.16% 76
2022
Q1
Sell
-3,540
Closed -$255K 88
2021
Q4
$255K Buy
+3,540
New +$222K 0.17% 80

Other funds holding LRCX

Consilium Wealth Advisory's LRCX Position: Q1 2026 in Review

Consilium Wealth Advisory increased its Lam Research (LRCX) stake by 111% in Q1 2026, buying an estimated $876K and bringing the position to 7,458 shares worth $1.59M. The position accounts for 0.54% of the portfolio, ranked #34.

Consilium Wealth Advisory first reported a position in LRCX in Q4 2021 and has held it in 13 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Consilium Wealth Advisory held 7,458 shares of Lam Research worth $1.59M as of Q1 2026.
  • Consilium Wealth Advisory bought 3,918 Lam Research shares in Q1 2026, an estimated $876K.
  • Lam Research made up 0.54% of Consilium Wealth Advisory's portfolio in Q1 2026, its #34 holding.
  • Consilium Wealth Advisory first reported a position in Lam Research in Q4 2021 and has held it in 13 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Consilium Wealth Advisory's 13F filing for Q1 2026, filed 20 Apr 2026.